US Government As Represented by the Secretary of the Army

The Cleveland Clinic Foundation

The UAB Research Foundation (The University of Alabama at Birmingham)

Roslyn Bernstein Mannon

Jonathan A Forsberg

Thomas A Davis

Eric Elster

Robert L Fairchild

John S Eberhardt, Iii

Trevor S Brown

Doug K Tadaki

Jason Hawksworth

Alexander Stojadinovic

Provided herein are compositions, systems, kits, and methods for detecting rejection, or an elevated risk of rejection, of an organ or tissue graft (e.g., kidney graft) in a subject by detecting one, or a panel of, RNA markers in a urine sample from the subject. In certain embodiments, kidney graft injury is detected by measuring one or more of the RNA markers disclosed herein. In some embodiments, the one or more markers are employed to distinguish between acute graft rejection and BK virus nephropathy.

Urine biomarkers for detecting graft rejection

An embodiment of the invention provides a method for determining a patient-specific probability of transplant glomerulopathy. The method collects clinical parameters from a plurality of patients to create a training database. A fully unsupervised Bayesian Belief Network model is created using data from the training database; and, the fully unsupervised Bayesian Belief Network is validated. Clinical parameters are collected from an individual patient; and, such clinical parameters are input into the fully unsupervised Bayesian Belief Network model via a graphical user interface. The patient-specific probability of transplant glomerulopathy is output from the fully unsupervised Bayesian Belief Network model and sent to the graphical user interface for use by a clinician in pre-operative planning. The fully unsupervised Bayesian Belief Network model is updated using the clinical parameters from the individual patient and the patient-specific probability of transplant glomerulopathy.

Bayesian clinical decision model for determining probability of transplant glomerulopathy

Growing community of inventors

Birmingham, AL, United States of America

Roslyn Bernstein Mannon